Human mesenchymal stromal cells expanded with human platelet lysate are safe and effective for the treatment of steroid-refractory graft-versus-host disease

被引：0
|
作者：
Introna, M. [1 ]
Capelli, C. [1 ]
Mico, C. [1 ]
Algarotti, A. [1 ]
Grassi, A. [1 ]
Salvade, A. [2 ]
Gaipa, G. [2 ]
Belotti, D. [2 ]
Perseghin, P. [2 ]
D'Amico, G. [2 ]
Rovelli, A. [2 ]
Balduzzi, A. [2 ]
Golay, J. [1 ]
Golay, J. [1 ]
Biondi, A. [2 ]
Rambaldi, A. [1 ]
Biagi, E. [2 ]
机构：
[1] Lab Cellular Therapy G Lanzani, Bergamo, Italy
[2] Osped San Gerardo, Monza, Italy
来源：
BONE MARROW TRANSPLANTATION | 2009年 / 43卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S133 / S133
页数：1
相关论文
共 50 条
  • [41] Treatment and unmet needs in steroid-refractory acute graft-versus-host disease
    Malard, Florent
    Huang, Xiao-Jun
    Sim, Joycelyn P. Y.
    LEUKEMIA, 2020, 34 (05) : 1229 - 1240
  • [42] Brentixumab vedotin for the treatment of steroid-refractory chronic graft-versus-host disease
    DeFilipp, Zachariah
    Li, Shuli
    Kempner, Maria
    Brown, Jami
    Del Rio, Candice
    Valles, Betsy
    Ballen, Karen
    Dey, Bimalangshu
    El-Jawahri, Areej
    McAfee, Steven
    Spitzer, Thomas
    Chen, Yi-Bin
    BONE MARROW TRANSPLANTATION, 2018, 53 : 398 - 398
  • [43] Daclizumab, an efficient treatment for steroid-refractory acute graft-versus-host disease
    Bordigoni, Pierre
    Dimicoli, Sophie
    Clement, Laurence
    Baumann, Cedric
    Salmon, Alexandra
    Witz, Francis
    Feugier, Pierre
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (03) : 382 - 385
  • [44] Treatment and unmet needs in steroid-refractory acute graft-versus-host disease
    Florent Malard
    Xiao-Jun Huang
    Joycelyn P. Y. Sim
    Leukemia, 2020, 34 : 1229 - 1240
  • [45] Low dose alemtuzumab is effective in the treatment of severe steroid-refractory acute graft-versus-host disease
    Repp, R
    Claviez, A
    Gahn, B
    Schub, N
    Beck, C
    Helm, F
    Gramatzki, M
    BONE MARROW TRANSPLANTATION, 2006, 37 : S97 - S97
  • [46] Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease
    Stenger, Elizabeth
    Giver, Cynthia R.
    Langston, Amelia
    Kota, Daniel
    Das, Pankoj Kumar
    Chinnadurai, Raghavan
    Galipeau, Jacques
    Waller, Edmund K.
    Qayed, Muna
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [47] Expanded cryopreserved mesenchymal stromal cells as an optimal source for graft-versus-host disease treatment
    Holubova, Monika
    Lysak, Daniel
    Vlas, Tomas
    Vannucci, Luca
    Jindra, Pavel
    BIOLOGICALS, 2014, 42 (03) : 139 - 144
  • [48] THE OPTIMIZATION OF MESENCHYMAL STROMAL CELLS PRODUCTION FOR THE TREATMENT OF STEROID REFRACTORY GRAFT VERSUS HOST DISEASE
    Lysak, D.
    Holubova, M.
    Jindra, P.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S543 - S543
  • [49] Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease Using Commercial Mesenchymal Stem Cell Products
    Murata, Makoto
    Teshima, Takanori
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [50] Ruxolitinib for steroid-refractory graft-versus-host disease: A case series
    Lancman, Guido
    Coltoff, Alexander
    Steinberg, Amir
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (03) : 611 - 613
12345